Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations.
A retrospective pilot study was conducted to determine whether a relatively brief integrated outpatient treatment for patients with dual disorders reduced inpatient hospital service utilization. Outpatients (n=44) with substance dependence and either comorbid schizophrenia, major depressive disorder, or bipolar disorder were studied. A multidisciplinary team provided relatively brief (up to 24 weeks), integrated, dual-diagnosis outpatient treatment. A significant 60% reduction in the number of psychiatric hospitalization days was found for the year after treatment as compared to the year before. Patients with schizophrenia showed the greatest reduction (74%) in hospitalization days. Thus, even brief integrated outpatient dual-diagnosis treatment can reduce inpatient psychiatric hospitalizations.
D000328:Adult; D000437:Alcoholism / Q000175:diagnosis / Q000534:rehabilitation*; D000553:Ambulatory Care / Q000706:statistics & numerical data*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000534:rehabilitation*; D002140:California; D003131:Combined Modality Therapy; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000534:rehabilitation*; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D006787:Hospitals, Veterans / Q000706:statistics & numerical data; D006801:Humans; D013287:Illicit Drugs; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D010359:Patient Readmission / Q000706:statistics & numerical data*; D011615:Psychotherapy, Group; D012189:Retrospective Studies; D012559:Schizophrenia / Q000175:diagnosis / Q000534:rehabilitation*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000534:rehabilitation*; D016896:Treatment Outcome; D014600:Utilization Review / Q000706:statistics & numerical data
D013287:Illicit Drugs